PMID: 10516610Oct 12, 1999

Expression of CD134 (0X-40) on T cells during the first 100 days following allogeneic bone marrow transplantation as a marker for lymphocyte activation and therapy-resistant graft-versus-host disease

L S LambA P Gee


CD134 (OX-40) is an activation-associated antigen which functions as a costimulatory receptor for CD4+ T cells. In order to determine the expression of CD134 during immune recovery following allogeneic bone marrow transplantation (BMT), we measured its expression on T cells and T cell subsets during the first 100 days following BMT in 26 patients. CD4+CD134+ T could be seen approximately 14 days following BMT cells in patients who did not develop GvHD which required therapy (n = 20). The percentage of CD4+CD134+ cells continued to increase up to the fourth week following BMT to a maximum of 40-50% of CD4+ T cells (normal = 1-8%). Two patients who developed Grade I-II GvHD and who responded to treatment with pulsed high-dose methylprednisolone (MPD) showed a decline of approximately 40% in CD4+CD134+ T cells was seen within 48 hours of treatment. Four patients who developed GvHD that was not responsive to MPD and who later developed high IV GvHD showed increasing CD4+CD134+ T cells up to 85% of the CD4+ T cells. Additionally, rapid increases in CD134+ T cells following antibody-based T cell therapy were associated with GvHD recurrence. In no cases was the percentage of CD134+ CD4+ T cells predictive of clinical GvHD. In this exp...Continue Reading


Jun 3, 2004·Nature Reviews. Immunology·Kazuo SugamuraAndrew D Weinberg
Jun 24, 2006·Clinical and Experimental Immunology·M Paz MoranteS Vidal
Apr 6, 2005·Transplantation Proceedings·Y MiuraA D Hess
Jan 1, 1999·Cytotherapy·A P Gee
Apr 28, 2004·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Philip R StreeterRichard T Maziarz
Dec 20, 2019·Journal of Virology·Bochao WangYasuko Mori


Jan 26, 1989·The New England Journal of Medicine·C AnasettiE M Mickelson
Sep 26, 1985·The New England Journal of Medicine·P G BeattyR Storb
Apr 10, 1997·The New England Journal of Medicine·P J Barnes, M Karin
Feb 12, 1998·Proceedings of the National Academy of Sciences of the United States of America·K De BosscherG Haegeman

Related Concepts

Flow Cytometry
CD4 Antigens
OX40 Receptors
Tumor Necrosis Factor Receptor
Graft-vs-Host Disease
Bone Marrow
Recurrent Malignant Neoplasm
TNFRSF4 wt Allele

Related Feeds


Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.